A small study of Amgen Inc.’s Lumakras drug combined with immunotherapy found it helped 29% of advanced lung cancer patients, but liver toxicity was high and further study is needed, the company said ahead of the data presentation on Sunday at the World Conference on Lung Cancer in Vienna.
A collaborative team of researchers from Harvard University, Columbia University and Rutgers University has unlocked the mechanism of the danger signal adenosine triphosphate (ATP). The discovery could go on to influence the way in which immunomodulators, such as vaccines and allergy medications, are formulated.
Russia has registered a total of 820,307 COVID-related deaths since the start of the pandemic in the country in April 2020, the state statistics service Rosstat said on Friday.
The drug received priority review and breakthrough therapy designations for the indication, and approval was granted to Daiichi Sankyo four months ahead of the Prescription Drug User Fee Act deadline.
The United States has administered more than 7,300 doses of Novavax Inc.’s (NVAX.O) COVID-19 shot, which health officials hope will convince more people to opt for vaccinations as it is based on a technology that has been in use for decades.
Global pharma giant Sanofi and Chinese company Innovent Biologics have penned a strategic partnership to develop and commercialize innovative treatments for patients with hard-to-treat cancers in China.
